If you want to eliminate the half-hearted CPR known as the “slow code,” you have to eliminate the conditions that make them necessary, two bioethicist...

Companies in a burgeoning field of mRNA therapeutics express shock at HHS' deep cuts to research funding.

Cancer vaccines in development rely on mRNA technology under attack by RFK Jr. “I am concerned that this could bleed over," an oncologist says.

An investigation by Sens. Ron Wyden and Elizabeth Warren is another setback for UnitedHealth, which recently laid out a lower profit outlook and promi...

Might Alnylam be the next mega-cap biotech? It has momentum.

Eli Lilly has hoped its candidate weight loss pill would safeguard its lead in the obesity market, but new results may prove disappointing.

Some octogenarians have exceptionally sharp memories, even sharper than people who are decades younger. A new analysis of their brains could help expl...

And other health new stories of the day.

Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer therapy may be hindered

Plus more biotech news of the day, brought to you by The Readout.